Outcomes of graciloplasty in the treatment of fecal incontinence: a systematic review and meta-analysis of the literature.


Journal

Techniques in coloproctology
ISSN: 1128-045X
Titre abrégé: Tech Coloproctol
Pays: Italy
ID NLM: 9613614

Informations de publication

Date de publication:
06 2023
Historique:
received: 14 06 2022
accepted: 14 11 2022
medline: 11 5 2023
pubmed: 9 12 2022
entrez: 8 12 2022
Statut: ppublish

Résumé

Patients with refractory fecal incontinence symptoms can be treated with several surgical procedures including graciloplasty. Reported outcomes and morbidity rates of this procedure are highly variable. The aim of this study was to assess continence rate and safety of dynamic and adynamic graciloplasty. PubMed and Google Scholar databases were systematically searched from inception until January 2022 according to preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines. Reviews, animal studies, studies with patients < 18 years or < 10 patients, with no success rate reported or non-English text, were excluded. Main outcome measures were overall continence and morbidity rates of each technique. Fourteen studies were identified, incorporating a total of 450 patients (337 females), published between 1980 and 2021. Most common etiology of incontinence (35.5%-n = 160) was obstetric trauma followed by anorectal trauma (20%-n = 90). The weighted mean rate of continence after dynamic graciloplasty was 69.1% (95% CI 0.53-0.84%, I Our data suggest that graciloplasty may be considered for incontinent patients. Dynamic graciloplasty may harbor higher risk for reoperation and complications compared to adynamic. The fact that the functional results between adynamic and dynamic graciloplasty are equivalent and the morbidity rate of adynamic graciloplasty is significantly lower reinforce the graciloplasty as an option to treat appropriately selected patients with fecal incontinence.

Sections du résumé

BACKGROUND
Patients with refractory fecal incontinence symptoms can be treated with several surgical procedures including graciloplasty. Reported outcomes and morbidity rates of this procedure are highly variable. The aim of this study was to assess continence rate and safety of dynamic and adynamic graciloplasty.
METHODS
PubMed and Google Scholar databases were systematically searched from inception until January 2022 according to preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines. Reviews, animal studies, studies with patients < 18 years or < 10 patients, with no success rate reported or non-English text, were excluded. Main outcome measures were overall continence and morbidity rates of each technique.
RESULTS
Fourteen studies were identified, incorporating a total of 450 patients (337 females), published between 1980 and 2021. Most common etiology of incontinence (35.5%-n = 160) was obstetric trauma followed by anorectal trauma (20%-n = 90). The weighted mean rate of continence after dynamic graciloplasty was 69.1% (95% CI 0.53-0.84%, I
CONCLUSIONS
Our data suggest that graciloplasty may be considered for incontinent patients. Dynamic graciloplasty may harbor higher risk for reoperation and complications compared to adynamic. The fact that the functional results between adynamic and dynamic graciloplasty are equivalent and the morbidity rate of adynamic graciloplasty is significantly lower reinforce the graciloplasty as an option to treat appropriately selected patients with fecal incontinence.

Identifiants

pubmed: 36479654
doi: 10.1007/s10151-022-02734-6
pii: 10.1007/s10151-022-02734-6
doi:

Types de publication

Meta-Analysis Systematic Review Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

429-441

Informations de copyright

© 2022. Springer Nature Switzerland AG.

Références

Madoff RD, Rosen HR, Baeten CG et al (1999) Safety and efficacy of dynamic muscle plasty for anal incontinence: lessons from a prospective, multicenter trial. Gastroenterology 116:549–556. https://doi.org/10.1016/s0016-5085(99)70176-9 (PMID: 10029613)
doi: 10.1016/s0016-5085(99)70176-9 pubmed: 10029613
Walega P, Romaniszyn M, Siarkiewicz B, Zelazny D (2015) Dynamic versus adynamic graciloplasty in treatment of end-stage fecal incontinence: is the implantation of the pacemaker really necessary? 12-month follow-up in a clinical, physiological, and functional study. Gastroenterol Res Pract 2015:698516. https://doi.org/10.1155/2015/698516 (Epub 2015 Mar 11. PMID: 25861261; PMCID: PMC4377477)
doi: 10.1155/2015/698516 pubmed: 25861261 pmcid: 4377477
Brown HW, Wexner SD, Segall MM, Brezoczky KL, Lukacz ES (2012) Quality of life impact in women with accidental bowel leakage. Int J Clin Pract 66:1109–1116. https://doi.org/10.1111/ijcp.12017 (PMID: 23067035)
doi: 10.1111/ijcp.12017 pubmed: 23067035
Brown HW, Wexner SD, Lukacz ES (2013) Factors associated with care seeking among women with accidental bowel leakage. Female Pelvic Med Reconstr Surg 19:66–71. https://doi.org/10.1097/SPV.0b013e31828016d3 (PMID: 23442502)
doi: 10.1097/SPV.0b013e31828016d3 pubmed: 23442502
Brown HW, Wexner SD, Segall MM, Brezoczky KL, Lukacz ES (2012) Accidental bowel leakage in the mature women’s health study: prevalence and predictors. Int J Clin Pract 66:1101–1108. https://doi.org/10.1111/ijcp.12018 (PMID: 23067034)
doi: 10.1111/ijcp.12018 pubmed: 23067034
Ng KS, Sivakumaran Y, Nassar N, Gladman MA (2015) Fecal incontinence: community prevalence and associated factors—a systematic review. Dis Colon Rectum 58:1194–1209. https://doi.org/10.1097/DCR.0000000000000514 (PMID: 26544818)
doi: 10.1097/DCR.0000000000000514 pubmed: 26544818
Halland M, Koloski NA, Jones M et al (2013) Prevalence correlates and impact of fecal incontinence among older women. Dis Colon Rectum 56:1080–1086. https://doi.org/10.1097/DCR.0b013e31829203a9 (PMID: 23929018)
doi: 10.1097/DCR.0b013e31829203a9 pubmed: 23929018
Rey E, Choung RS, Schleck CD (2010) Onset and risk factors for fecal incontinence in a US community. Am J Gastroenterol 105:412–419. https://doi.org/10.1038/ajg.2009.594 (Epub 2009 Oct 20. PMID: 19844202; PMCID: PMC3189687)
doi: 10.1038/ajg.2009.594 pubmed: 19844202
Aitola P, Lehto K, Fonsell R, Huhtala H (2010) Prevalence of faecal incontinence in adults aged 30 years or more in general population. Colorectal Dis 12:687–691. https://doi.org/10.1111/j.1463-1318.2009.01878.x (Epub 2009 Apr 10 PMID: 19486087)
doi: 10.1111/j.1463-1318.2009.01878.x pubmed: 19486087
Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https://doi.org/10.1136/bmj.n71
doi: 10.1136/bmj.n71 pubmed: 33782057 pmcid: 8005924
Sterne JA, Hernán MA, Reeves BC et al (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355:i4919. https://doi.org/10.1136/bmj.i4919 (PMID: 27733354; PMCID: PMC5062054)
doi: 10.1136/bmj.i4919 pubmed: 27733354 pmcid: 5062054
Balshem H, Helfand M, Schunemann HJ et al (2011) GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 64:401–406
doi: 10.1016/j.jclinepi.2010.07.015 pubmed: 21208779
Oxford Centre for Evidence-Based Medicine OCEBM Levels of Evidence Working Group (2021) The Oxford Levels of Evidence 2 [(accessed on 11 Nov 2021)]; Available online: https://www.cebm.ox.ac.uk/resources/levels-of-evidence/ocebm-levels-of-evidence
Corman ML (1980) Follow-up evaluation of gracilis muscle transposition for fecal incontinence. Dis Colon Rectum 23:552–555. https://doi.org/10.1007/BF02988994 (PMID: 7460691)
doi: 10.1007/BF02988994 pubmed: 7460691
Geerdes BP, Heineman E, Konsten J, Soeters PB, Baeten CG (1996) Dynamic graciloplasty Complications and management. Dis Colon Rectum 39:912–917. https://doi.org/10.1007/BF02053991 (PMID: 8756848)
doi: 10.1007/BF02053991 pubmed: 8756848
Christiansen J, Sørensen M, Rasmussen OO (1990) Gracilis muscle transposition for faecal incontinence. Br J Surg 77:1039–1040. https://doi.org/10.1002/bjs.1800770928 (PMID: 2207570)
doi: 10.1002/bjs.1800770928 pubmed: 2207570
Wexner SD, Gonzalez-Padron A, Rius J et al (1996) Stimulated gracilis neosphincter operation. Initial experience, pitfalls, and complications. Dis Colon Rectum 39:957–964. https://doi.org/10.1007/BF02054681 (PMID: 8797641)
doi: 10.1007/BF02054681 pubmed: 8797641
Christiansen J, Rasmussen OO, Lindorff-Larsen K (1998) Dynamic graciloplasty for severe anal incontinence. Br J Surg 85:88–91. https://doi.org/10.1046/j.1365-2168.1998.00506.x (PMID: 9462392)
doi: 10.1046/j.1365-2168.1998.00506.x pubmed: 9462392
Eccersley AJ, Lunniss PJ, Williams NS (1999) Unstimulated graciloplasty in traumatic faecal incontinence. Br J Surg 86:1071–1072. https://doi.org/10.1046/j.1365-2168.1999.01159.x (PMID: 10460647)
doi: 10.1046/j.1365-2168.1999.01159.x pubmed: 10460647
Mavrantonis C, Billotti VL, Wexner SD (1999) Stimulated graciloplasty for treatment of intractable fecal incontinence: critical influence of the method of stimulation. Dis Colon Rectum 42:497–504. https://doi.org/10.1007/BF02234176 (Erratum in: Dis Colon Rectum 1999 May;42(5):578. PMID: 10215051)
doi: 10.1007/BF02234176 pubmed: 10215051
Sielezneff I, Malouf AJ, Bartolo DC, Pryde A, Douglas S (1999) Dynamic graciloplasty in the treatment of patients with faecal incontinence. Br J Surg 86(1):61–65. https://doi.org/10.1046/j.1365-2168.1999.00936.x (PMID: 10027361)
doi: 10.1046/j.1365-2168.1999.00936.x pubmed: 10027361
Wexner SD, Baeten C, Bailey R et al (2002) Long-term efficacy of dynamic graciloplasty for fecal incontinence. Dis Colon Rectum 45:809–818. https://doi.org/10.1007/s10350-004-6302-1 (PMID: 12072635)
doi: 10.1007/s10350-004-6302-1 pubmed: 12072635
Boyle DJ, Murphy J, Hotouras A, Allison ME, Williams NS, Chan CL (2014) Electrically stimulated gracilis neosphincter for end-stage fecal incontinence: the long-term outcome. Dis Colon Rectum 57:215–222. https://doi.org/10.1097/DCR.0b013e3182a4b55f (PMID: 24401884)
doi: 10.1097/DCR.0b013e3182a4b55f pubmed: 24401884
Kulkarni J, Patil AJ, Musande B, Bhamare AB (2016) Management of fourth degree obstetric perineal tear without colostomy using non—stimulated gracilis—our experience over eleven years. Indian J Plast Surg 49:26–34. https://doi.org/10.4103/0970-0358.182236.PMID:27274119;PMCID:PMC4878240
doi: 10.4103/0970-0358.182236.PMID:27274119;PMCID:PMC4878240 pubmed: 27274119 pmcid: 4878240
Gohil AJ, Gupta AK, Jesudason MR, Nayak S (2019) Graciloplasty for anal incontinence-is electrical stimulation necessary? Ann Plast Surg 82:671–678. https://doi.org/10.1097/SAP.0000000000001770 (PMID: 30633015)
doi: 10.1097/SAP.0000000000001770 pubmed: 30633015
Mege D, Omouri A, Maignan A, Sielezneff I (2021) Long-term results of dynamic graciloplasty for severe fecal incontinence. Tech Coloproctol 25:531–537. https://doi.org/10.1007/s10151-021-02421-y (Epub 2021 Feb 15 PMID: 33590438)
doi: 10.1007/s10151-021-02421-y pubmed: 33590438
Knol ME, Snijders HS, DeRuiter MC et al (2021) Non-dynamic graciloplasty is an effective treatment for patients with passive fecal incontinence. Tech Coloproctol 25:849–855. https://doi.org/10.1007/s10151-021-02455-2 (Epub 2021 May 12 PMID: 33978860)
doi: 10.1007/s10151-021-02455-2 pubmed: 33978860
Paquette IM, Varma MG, Kaiser AM, Steele SR, Rafferty JF (2015) The American Society of Colon and Rectal Surgeons’ Clinical Practice Guideline for the treatment of fecal incontinence. Dis Colon Rectum 58:623–636. https://doi.org/10.1097/DCR.0000000000000397 (PMID: 26200676)
doi: 10.1097/DCR.0000000000000397 pubmed: 26200676
Kaiser AM, Orangio GR, Zutshi M et al (2014) Current status: new technologies for the treatment of patients with fecal incontinence. Surg Endosc 28:2277–2301. https://doi.org/10.1007/s00464-014-3464-3
doi: 10.1007/s00464-014-3464-3 pubmed: 24609699
Pickrell KL, Broadbent TR, Masters FW et al (1952) Construction of a rectal sphincter and restoration of anal continence by transplanting the gracilis muscle: a report of four cases in children. Ann Surg 135:853
doi: 10.1097/00000658-195206000-00010 pubmed: 14924540 pmcid: 1802208
Dickson JAS, Nixon HH (1968) Control by electronic stimulator of incontinence after operation for anorectal agenesis. J Pediatr Surg 3:696–701
doi: 10.1016/0022-3468(68)90901-9
Baeten CG, Konsten J, Spaans F et al (1991) Dynamic graciloplasty for treatment of faecal incontinence. Lancet 338:1163–1165. https://doi.org/10.1016/0140-6736(91)92030-6 (PMID: 1682590)
doi: 10.1016/0140-6736(91)92030-6 pubmed: 1682590
Williams NS, Patel J, George BD, Hallan RI, Watkins ES (1991) Development of an electrically stimulated neoanal sphincter. Lancet 338:1166–1169
doi: 10.1016/0140-6736(91)92031-V pubmed: 1682591
Bresler L, Reibel N, Brunaud L et al (2002) Dynamic graciloplasty in the treatment of severe fecal incontinence. French multicentric retrospective study. Ann Chir 127:520–526
doi: 10.1016/S0003-3944(02)00828-3 pubmed: 12404846
Rongen M-JGM, Uludag O, El Naggar K, Geerdes BP, Konsten J, Baeten CGMI (2003) Long-term follow-up of dynamic graciloplasty for fecal incontinence. Dis Colon Rectum 46:716–721
doi: 10.1007/s10350-004-6645-7 pubmed: 12794571
Hassan MZM, Rathnayaka MMG, Deen KI (2010) Modified dynamic gracilis neosphincter for fecal incontinence: an analysis of functional outcome at a single institution. World J Surg 34:1641–1647
doi: 10.1007/s00268-010-0489-1 pubmed: 20180122
Thornton MJ, Kennedy ML, Lubowski DZ, King DW (2004) Long-term follow-up of dynamic graciloplasty for faecal incontinence. Colorectal Dis 6:470–476
doi: 10.1111/j.1463-1318.2004.00714.x pubmed: 15521938
Sonnino RE, Reinberg O, Bensoussan AL, Laberge JM, Blanchard H (1991) Gracilis muscle transposition for anal incontinence in children: long-term follow-up. J Pediatr Surg 26:1219–1223
doi: 10.1016/0022-3468(91)90338-T pubmed: 1779332
Haizlip KM, Harrison BC, Leinwand LA (2015) Sex-based differences in skeletal muscle kinetics and fiber-type composition. Physiology (Bethesda) 30:30–39. https://doi.org/10.1152/physiol.00024.2014 (PMID: 25559153; PMCID: PMC4285578)
doi: 10.1152/physiol.00024.2014 pubmed: 25559153 pmcid: 4285578
Chapman AE, Geerdes B, Hewett P et al (2002) Systematic review of dynamic graciloplasty in the treatment of faecal incontinence. Br J Surg 89:138–153. https://doi.org/10.1046/j.0007-1323.2001.02018.x (PMID: 1185612)
doi: 10.1046/j.0007-1323.2001.02018.x pubmed: 11856125

Auteurs

Z Garoufalia (Z)

Ellen Leifer Shulman and Steven Shulman Digestive Disease Center, Department of Colorectal Surgery, Cleveland Clinic Florida, 2950 Cleveland Clinic Blvd., Weston, FL, 33331, USA.

R Gefen (R)

Ellen Leifer Shulman and Steven Shulman Digestive Disease Center, Department of Colorectal Surgery, Cleveland Clinic Florida, 2950 Cleveland Clinic Blvd., Weston, FL, 33331, USA.
Department of General Surgery, Faculty of Medicine, Hadassah Medical Organization, Hebrew University of Jerusalem, Jerusalem, Israel.

S H Emile (SH)

Ellen Leifer Shulman and Steven Shulman Digestive Disease Center, Department of Colorectal Surgery, Cleveland Clinic Florida, 2950 Cleveland Clinic Blvd., Weston, FL, 33331, USA.
Colorectal Surgery Unit, General Surgery Department, Mansoura University Hospitals, Mansoura, Egypt.

E Silva-Alvarenga (E)

Martin Health at Tradition HealthPark Two, Cleveland Clinic Florida, Weston, FL, USA.

M R Freund (MR)

Ellen Leifer Shulman and Steven Shulman Digestive Disease Center, Department of Colorectal Surgery, Cleveland Clinic Florida, 2950 Cleveland Clinic Blvd., Weston, FL, 33331, USA.
Department of General Surgery, Shaare Zedek Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.

N Horesh (N)

Ellen Leifer Shulman and Steven Shulman Digestive Disease Center, Department of Colorectal Surgery, Cleveland Clinic Florida, 2950 Cleveland Clinic Blvd., Weston, FL, 33331, USA.
Department of Surgery and Transplantations, Sheba Medical Center, Ramat Gan, Israel.

S D Wexner (SD)

Ellen Leifer Shulman and Steven Shulman Digestive Disease Center, Department of Colorectal Surgery, Cleveland Clinic Florida, 2950 Cleveland Clinic Blvd., Weston, FL, 33331, USA. wexners@ccf.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH